10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023

Rhea-AI Summary

10x Genomics (TXG) plans to release its financial results for Q4 and full year 2022 on February 15, 2023, after market close. Management will host a conference call at 1:30 PM PT to discuss the results and provide insights on business developments and future outlook. The company's integrated solutions are essential in advancing biological research, with products utilized by top research institutions and pharmaceutical companies. The live webcast will be accessible on their website, with a replay available for at least 45 days.

Positive

• 10x Genomics products are used by all top 100 global research institutions and top 20 pharmaceutical companies.
• The company has over 1,700 issued patents and applications.

Negative

• None.

PLEASANTON, Calif., Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after market close on Wednesday, February 15, 2023. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2021 based on publications and all of the top 20 global pharmaceutical companies by 2021 research and development spend and have been cited in over 4,500 research papers on discoveries ranging from oncology to immunology and neuroscience. Our patent portfolio comprises more than 1,700 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-february-15-2023-301726238.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics report its financial results for Q4 2022?

10x Genomics will report its financial results on February 15, 2023.

What time will the conference call be held for 10x Genomics Q4 results?

The conference call will be held at 1:30 PM Pacific Time on February 15, 2023.

How can I access the webcast for 10x Genomics financial results?

The webcast will be available on the 'Investors' section of the 10x Genomics website.

What achievements does 10x Genomics highlight in its press release?

10x Genomics highlights its products being adopted by top research institutions and a robust patent portfolio.